Ashraf Malhas, PhD,  —

Articles by Ashraf Malhas

Low-Dose Oral Corticosteroids Offer More Promising Outcomes for MG Patients than Higher Doses

Researchers found that a low-dose regimen of oral corticosteroids is better than high- or intermediate-dose regimens in maintaining treatment goals for patients with myasthenia gravis (MG). The study “Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan” was published in the…